ArticleOncology letters2019

The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line.

Chengji Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.